{"id":"W2980200289","doi":"10.1182/blood.v116.21.1803.1803","title":"Front-Line Therapy with Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) Followed by 2 Years of Rituximab Maintenance for Follicular Lymphoma (FL) Is Associated with Excellent Outcomes and Improved Progression-Free Survival (PFS) In Comparison to No Maintenance","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Maintenance therapy; Population; Follicular lymphoma; Vincristine; Internal medicine; Hazard ratio; Surgery; Interim analysis; Chemotherapy regimen; Prednisone; Cyclophosphamide; Oncology; Cancer; Chemotherapy; Randomized controlled trial; Confidence interval; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000622385,0.0002480978,0.0007014798,0.0002482928,0.0001719354,0.0004082828,0.0003498838,0.0003715405,0.001319889],"category_scores_gemma":[0.0008986904,0.000122217,0.0005824224,0.0002433655,0.0002325203,0.0003419868,0.0002335897,0.0005883842,0.0002330388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006431785,"about_ca_system_score_gemma":0.0004199282,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001202796,"about_ca_topic_score_gemma":0.002485948,"domain_scores_codex":[0.9997763,0.00007086439,0.00001832874,0.00005492026,0.00003467486,0.00004490227],"domain_scores_gemma":[0.9993201,0.0001212015,0.0003015309,0.00004890813,0.0000265987,0.0001816946],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2462897,0.01029459,0.4401841,0.0005728927,0.002485995,0.0005670569,0.0001742202,0.002531428,0.01557694,0.0001145343,0.003500412,0.2777081],"study_design_scores_gemma":[0.01552231,0.113002,0.8625147,0.0001225133,0.001278424,0.001291943,0.00006223809,0.002505023,0.002061205,0.0001228153,0.001486124,0.00003069659],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978312,0.001502408,0.0001054916,0.00006197671,0.00001449997,0.00003250881,0.0001484624,0.00001231409,0.000291145],"genre_scores_gemma":[0.99863,0.0004175736,0.0001316827,0.0001008469,0.00004687944,0.00002237817,0.0004761494,0.000002116635,0.0001722022],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001319889,"threshold_uncertainty_score":0.004666626,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007413235680799319,"score_gpt":0.2505795066936167,"score_spread":0.2431662710128174,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}